Mark Peterson

A renewable energy company's leap into mining raises questions. Is it brilliant vertical integration or a high-risk gamble diluting its green mission?

Bicara Therapeutics' latest data for its dual-action antibody shows impressive consistency, de-risking its pivotal trial for a tough head and neck cancer.

With copper prices soaring, Amerigo renews its share buyback, doubling down on a shareholder-first strategy built on zero debt and market confidence.

Faraday Future's bold five-year plan targets 500,000 EVs, but with a history of delays and a critical need for cash, can it deliver or is it a dream?

With cash dwindling and a key trial missing its mark, IO Biotech faces a critical test at two investor conferences. Can it salvage its lead drug?

Adial Pharmaceuticals secures a crucial $2.86M, but the deal's structure raises serious questions about shareholder dilution versus fueling its promising AD04 drug.

TeraGo partners with cybersecurity giant Fortinet, a strategic move to challenge incumbents by bundling secure networking with its unique wireless assets.

After fatal safety events restricted its blockbuster Duchenne therapy, Sarepta is launching a pivotal new study. Can it reclaim a critical market?

New survival data for Inluriyo, precision insights for Verzenio, and a next-gen drug signal Lilly's aggressive strategy to dominate HR+ breast cancer.

Future Standard launches a semi-liquid PE fund, betting on the middle market's resilience. Can it deliver private returns with public-like access?

KULR Technology developed a key directed energy weapon battery in record time. But can its engineering speed outpace the risks of its bold crypto strategy?

Liberty Defense taps a specialized partner for HEXWAVE deployment, a strategic move to overcome financial hurdles and accelerate growth in the security market.

Sarepta's clinical progress in myotonic dystrophy signals a major diversification beyond Duchenne, leveraging a high-stakes siRNA partnership.

CSW Industrials expands its Specialized Reliability Solutions segment with the acquisitions of Hydrotex and ProAction Fluids, signaling a strategic focus on niche markets and infrastructure support.

Global steel giant ArcelorMittal cancels nearly 78 million treasury shares, signaling confidence and a commitment to returning capital to investors. The move is expected to significantly impact earnings per share.

Cenovus Energy completed a $2.6 billion debt offering and concurrent redemption, bolstering its financial position amidst a shifting energy landscape and signaling optimism for the Canadian energy sector.

Texas-based Cipher Mining secures $333M to expand its data center footprint, betting on HPC demand despite cryptocurrency market uncertainties. A deep dive into the company's strategy and its impact on the infrastructure landscape.

The energy conversion and control systems leader is boosting its share repurchase program to $1.8 billion, underscoring strong financial health and a commitment to delivering value to shareholders amid a dynamic market.

KBR and Axiom Space complete critical thermal vacuum test of next-gen lunar spacesuit, crucial for Artemis III mission. A historic facility and commercial partnerships drive innovation for a return to the Moon.

Bright Scholar Education is going private amid increased scrutiny of Chinese education firms and a broader trend of delistings. A deep dive into the deal, the company's financials, and the future of international education.